Aker Biomarine (Norway) Today
| AKBM Stock | 69.00 1.80 2.68% |
Performance21 of 100
| Odds Of DistressLess than 19
|
Aker Biomarine is selling for 69.00 as of the 19th of April 2024. This is a 2.68 percent increase since the beginning of the trading day. The stock's lowest day price was 67.7. Aker Biomarine has less than a 19 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. Equity ratings for Aker Biomarine AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Moving together with Aker Stock
| 0.78 | LSG | Lery Seafood Group | PairCorr |
| 0.69 | AGLX | Agilyx AS Earnings Call This Week | PairCorr |
Moving against Aker Stock
| 0.87 | IOX | Interoil Exploration and Split | PairCorr |
| 0.85 | CONTX | ContextVision AB Earnings Call This Week | PairCorr |
| 0.84 | EMGS | Electromagnetic Geoservices | PairCorr |
| 0.75 | TECO | Teco 2030Asa | PairCorr |
| 0.63 | RIVER | River Tech plc | PairCorr |
| 0.6 | ORK | Orkla ASA | PairCorr |
| 0.6 | AZT | Arcticzymes Technologies | PairCorr |
Aker Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aker Biomarine's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aker Biomarine or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Packaged Foods, Consumer Defensive (View all Sectors) |
Aker Biomarine AS (AKBM) is traded on Oslo Stock Exchange in Norway and employs 429 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aker Biomarine's market, we take the total number of its shares issued and multiply it by Aker Biomarine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aker Biomarine AS operates under Consumer Defensive sector and is part of Packaged Foods industry. The entity has 87.65 M outstanding shares.
Aker Biomarine AS has accumulated about 9.15 M in cash with 729 K of positive cash flow from operations.
Check Aker Biomarine Probability Of Bankruptcy
Ownership AllocationAker Biomarine holds a total of 87.65 Million outstanding shares. Aker Biomarine AS shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.01 percent of Aker Biomarine AS outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aker Ownership Details
Aker Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Aker Biomarine jumping above the current price in 90 days from now is about 6.19%. The Aker Biomarine AS probability density function shows the probability of Aker Biomarine stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Aker Biomarine AS has a beta of -0.0531. This suggests as returns on the benchmark increase, returns on holding Aker Biomarine are expected to decrease at a much lower rate. During a bear market, however, Aker Biomarine AS is likely to outperform the market. Additionally, aker Biomarine AS has an alpha of 0.6984, implying that it can generate a 0.7 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Aker Biomarine to move above the current price in 90 days from now is about 6.19 (This Aker Biomarine AS probability density function shows the probability of Aker Stock to fall within a particular range of prices over 90 days) .
Aker Biomarine AS Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Aker Biomarine market risk premium is the additional return an investor will receive from holding Aker Biomarine long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aker Biomarine. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Aker Biomarine's alpha and beta are two of the key measurements used to evaluate Aker Biomarine's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.89 | |||
| Semi Deviation | 1.32 | |||
| Standard Deviation | 2.57 | |||
| Variance | 6.59 |
Aker Stock Against Markets
Picking the right benchmark for Aker Biomarine stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Aker Biomarine stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Aker Biomarine is critical whether you are bullish or bearish towards Aker Biomarine AS at a given time. Please also check how Aker Biomarine's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aker Biomarine without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Aker Biomarine Corporate Management
Elected by the shareholders, the Aker Biomarine's board of directors comprises two types of representatives: Aker Biomarine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aker. The board's role is to monitor Aker Biomarine's management team and ensure that shareholders' interests are well served. Aker Biomarine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aker Biomarine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Trond Smedsrud | Ex Investments | Profile | |
| Tone Lorentzen | Ex Chain | Profile | |
| Lise Wiger | Financial Controller | Profile | |
| Sigve Nordrum | Ex Nutrition | Profile | |
| Katrine Klaveness | Chief Officer | Profile | |
| Seth French | Chief Inc | Profile | |
| Matts Johansen | Chief Officer | Profile |
How to buy Aker Stock?
Before investing in Aker Biomarine, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Aker Biomarine. To buy Aker Biomarine stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Aker Biomarine. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Aker Biomarine stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Aker Biomarine AS stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Aker Biomarine AS stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Aker Biomarine AS, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Aker Biomarine AS?
The danger of trading Aker Biomarine AS is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aker Biomarine is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aker Biomarine. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aker Biomarine AS is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aker Biomarine AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Aker Stock analysis
When running Aker Biomarine's price analysis, check to measure Aker Biomarine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aker Biomarine is operating at the current time. Most of Aker Biomarine's value examination focuses on studying past and present price action to predict the probability of Aker Biomarine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aker Biomarine's price. Additionally, you may evaluate how the addition of Aker Biomarine to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |